16th Jun 2006 11:13
Henderson Morley PLC16 June 2006 FOR IMMEDIATE RELEASE 16 JUNE 2006 HENDERSON MORLEY PLC (AIM) Business: Drug Discovery Company HENDERSON MORLEY SIGNS LETTER OF INTENT WITH EUROPEAN DERMATOLOGICAL COMPANY The Board of Henderson Morley plc, the AIM listed drug discovery company, announces that it has been in negotiations with a European dermatological company and those discussions have resulted in both companies signing a Letter of Intent. The Letter of Intent is a precursor to the Grant of a License Agreement for a new application of ICVT for the topical treatment of genital and labial herpes and certain other dysplasias. The licence will be a worldwide licence to bring the products to market through a programme of preclinical and clinical development of the treatment. Both parties intend to be legally bound by the terms of a Licence Agreement which is expected to be concluded by 31 July 2006. A further announcement will be made at that time. --ENDS-- Enquiries: HENDERSON MORLEY PLC Tel: 0121 442 4600 Andrew Knight, Chairman BREWIN DOLPHIN SECURITIES LTD Tel: 0113 241 0126 Neil Baldwin BISHOPSGATE COMMUNICATIONS LTD Tel: 020 7430 1600 Maxine Barnes Mobile: 07860 489571 Scott Robertson This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
HML.L